Phase II neoadjuvant trial with carboplatin and eribulin mesylate in patients with triple-negative breast cancer

被引：0
|
作者：
Barnato, Sara E.
Jeruss, Jacqueline Sara
Bethke, Kevin P.
Hansen, Nora M.
Khan, Seema Ahsan
Von Roenn, Jamie H.
Rosen, Steven T.
Gradishar, William John
Siziopikou, Kalliopi P.
Meservey, Caitlin
Kaklamani, Virginia G.
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Lynn Sage Comprehens Breast Ctr, Chicago, IL USA
[3] Lynn Sage Comprehens Canc Ctr, Chicago, IL USA
[4] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[5] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS1134
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant phase II trial with eribulin and carboplatin in patients with triple-negative breast cancer
    Giordano, Sara Barnato
    Rao, Shreyas
    Hamdan, Randala
    Jeruss, Jacqueline
    Bethke, Kevin
    Hansen, Nora
    Khan, Seema
    Von Roenn, Jamie
    Rosen, Steven
    Gradishar, William J.
    Siziopikou, Kalliopi
    Meservey, Caitlin
    Kaklamani, Virginia
    MOLECULAR CANCER RESEARCH, 2013, 11
  • [2] Neoadjuvant phase II trial with carboplatin and eribulin in triple negative breast cancer patients
    Giordano, S. B.
    Jeruss, J. S.
    Bethke, K. P.
    Hansen, N. M.
    Khan, S.
    Von Roenn, J.
    Rosen, S.
    Gradishar, W. L.
    Siziopikou, K. P.
    Meservey, C.
    Kaklamani, V.
    CANCER RESEARCH, 2013, 73
  • [3] Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer
    Yuan, Yuan
    Lee, Jin Sun
    Yost, Susan E.
    Li, Sierra Min
    Frankel, Paul H.
    Ruel, Christopher
    Schmolze, Daniel
    Robinson, Kim
    Tang, Aileen
    Martinez, Norma
    Stewart, Daphne
    Waisman, James
    Kruper, Laura
    Jones, Veronica
    Menicucci, Andrea
    Uygun, Sahra
    Yoder, Erin
    van der Baan, Bastiaan
    Yim, John H.
    Yeon, Christina
    Somlo, George
    Mortimer, Joanne
    ONCOLOGIST, 2021, 26 (03): : E382 - E393
  • [4] Androgen receptor (AR) expression in triple negative breast cancer (TNBC): results from a phase II neoadjuvant trial with carboplatin and eribulin mesylate in TNBC patients
    Siziopikou, K.
    Parini, V.
    Kaklamani, V.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 14 - 14
  • [5] Neoadjuvant eribulin plus carboplatin vs. paclitaxel plus carboplatin in patients with triple-negative breast cancer (TNBC)
    Gigolaeva, L.
    Krivorotko, P.
    Khadzhimatova, S.
    Zhiltsova, E.
    Yerechshenko, S.
    Nikitina, M.
    Ni, V.
    Emelyanov, A.
    Imyanitov, E. N.
    Sokolenko, A. P.
    Tabagua, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] A phase II trial of neoadjuvant apatinib combined with nab-paclitaxel and carboplatin in triple-negative breast cancer
    Zeng, Tianyu
    Wang, Jue
    Li, Wei
    Sun, Chunxiao
    Yang, Fan
    Liang, Yan
    Fu, Ziyi
    Zha, Xiaoming
    Yin, Yongmei
    ANNALS OF ONCOLOGY, 2022, 33 : S492 - S492
  • [7] Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial
    Cristiano de Pádua Souza
    Ana Suellen Barroso Carneiro
    Ana Cecília de Oliveira Lessa
    Domício Carvalho Lacerda
    Carlos Eduardo Paiva
    Marina Moreira Costa Zorzetto
    Ana Julia Aguiar de Freitas
    Iara Viana Vidigal Santana
    Marco Antonio de Oliveira
    Edenir Inêz Palmero
    Márcia Maria Chiquitelli Marques
    Tomás Reinert
    Breast Cancer Research and Treatment, 2023, 202 : 57 - 65
  • [8] Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial
    Souza, Cristiano de Padua
    Carneiro, Ana Suellen Barroso
    Lessa, Ana Cecilia de Oliveira
    Lacerda, Domicio Carvalho
    Paiva, Carlos Eduardo
    Zorzetto, Marina Moreira Costa
    de Freitas, Ana Julia Aguiar
    Santana, Iara Viana Vidigal
    de Oliveira, Marco Antonio
    Palmero, Edenir Inez
    Marques, Marcia Maria Chiquitelli
    Reinert, Tomas
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 202 (01) : 57 - 65
  • [9] Phase 2 study of eribulin mesylate in combination with carboplatin in patients with advanced triple negative breast cancer.
    Michalaki, Vasiliki
    Karvouni, Eleni
    Dafnios, Nikolaos
    Psychogios, Christos
    Vasiliou, John
    Papadimitriou, Christos A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Genomic profile and response prediction of eribulin mesylate-based neoadjuvant chemotherapy in triple-negative breast cancer patients
    Nishimura, T.
    Masuda, N.
    Kawaguchi, K.
    Takada, M.
    Maeshima, Y.
    Tanaka, S.
    Velaga, R.
    Kikawa, Y.
    Kadoya, T.
    Bando, H.
    Nakamura, R.
    Yamamoto, Y.
    Ueno, T.
    Yasojima, H.
    Ishiguro, H.
    Morita, S.
    Ohno, S.
    Haga, H.
    Ogawa, S.
    Toi, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S424 - S425
12345